Tom Zanardi, PhD, DABT

Executive Director
Ionis Pharmaceuticals
Carlsbad, California, United States

Presentation(s):

• Advances and Challenges in Oligonucleotide and mRNA Therapeutics: New Strategies and Regulatory Perspectives (S12)

  Tuesday, November 19, 2024
  2:00 PM - 5:00 PM CT

• Expanding the Reach of Antisense Therapeutics: Facing Challenges Associated with Nonclinical Safety Assessment for Local IT Administration (S12-4)

  Tuesday, November 19, 2024
  3:45 PM - 4:15 PM CT